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Abstract
Tissue-specific autoimmune diseases are assumed to arise through malfunction of two checkpoints 
for immune tolerance: defective elimination of autoreactive T cells in the thymus and activation of 
these T cells by corresponding autoantigens in the periphery. However, evidence for this model 
and the outcome of such alterations in each or both of the tolerance mechanisms have not been 
sufficiently investigated. We studied these issues by expressing human AIRE (huAIRE) as a modifier 
of tolerance function in NOD mice wherein the defects of thymic and peripheral tolerance together 
cause type I diabetes (T1D). Additive huAIRE expression in the thymic stroma had no major impact 
on the production of diabetogenic T cells in the thymus. In contrast, huAIRE expression in peripheral 
antigen-presenting cells (APCs) rendered the mice resistant to T1D, while maintaining other tissue-
specific autoimmune responses and antibody production against an exogenous protein antigen, 
because of the loss of Xcr1+ dendritic cells, an essential component for activating diabetogenic T 
cells in the periphery. These results contrast with our recent demonstration that huAIRE expression 
in both the thymic stroma and peripheral APCs resulted in the paradoxical development of 
muscle-specific autoimmunity. Our results reveal that tissue-specific autoimmunity is differentially 
controlled by a combination of thymic function and peripheral tolerance, which can be manipulated 
by expression of huAIRE/Aire in each or both of the tolerance mechanisms.
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Introduction
Tissue-specific autoimmune diseases are assumed to arise 
through malfunction of two immune tolerance checkpoints: 
defective elimination of autoreactive T cells in the thymus and 
activation of these T cells by corresponding autoantigens in 
the periphery. Likewise, two critical steps for the develop-
ment of type I diabetes (T1D) have been suggested in NOD 
mice, a murine model of T1D in humans (1–3): generation of T 
cells reactive against β-islet antigens in the thymus, followed 
by activation of potentially diabetogenic T cells specific for 
β-islet antigens in the target organ and/or peripheral lymph 
nodes (LNs) (4). In the thymus, β-islet antigens are expressed 
by medullary thymic epithelial cells (mTECs), and presented 
by mTECs and/or dendritic cells (DCs) to purge autoreactive 
T cells (5, 6). Several lines of evidence have suggested that 
the expression level of insulin, a primary autoantigen in the 
pathogenesis of T1D (7), in mTECs is a critical determinant for 
elimination of diabetogenic T cells. For example, it has been 
reported that the T1D protective class III variable number of 
tandem repeats (VNTRs) in humans is associated with a higher 
steady-state level of insulin mRNA expression in the thymus (8, 
9). Conversely, knockout of insulin 2 (Ins2) in NOD accelerates 
the development of T1D (10, 11), most likely because of ineffi-
cient clonal deletion of Ins2-reactive T cells in the thymus. Aire, 
the gene responsible for the hereditary autoimmune disease 
APECED (autoimmune polyendocrinopathy-candidiasis-
ectodermal dystrophy), is one of the best-characterized 
factors responsible for controlling the expression levels of 
tissue-restricted self-antigens (TRAs), such as Ins2, in mTECs, 
thereby contributing to the establishment of self-tolerance 
in the thymus (12–14). In the periphery, autoreactive T cells 
that have escaped negative selection in the thymus subse-
quently become activated by interaction with corresponding 
self-antigens to attack target tissues if the peripheral toler-
ance mechanism does not function appropriately. Indeed, it 
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has been demonstrated that presentation of insulin peptide 
by antigen-presenting cells (APCs) in pancreatic β-islets and 
peripheral LNs, not confined to pancreatic LNs (4), is a critical 
step for diabetogenesis in NOD (15).
Although Aire expression is most prominent in mTECs, 
it is also expressed by bone marrow (BM)-derived non-
conventional APCs that show high MHC-II expression in 
secondary lymphoid organs, so-called extra-thymic Aire-
expressing cells (eTACs) (16, 17). eTACs have been sug-
gested to reinforce immune tolerance by preventing the 
maturation of autoreactive T cells that have escaped thymic 
negative selection. B cells in the thymus also express Aire, and 
their role in thymic tolerance has been suggested (18). Given 
that Aire exerts its tolerogenic function in both mTECs and 
BM-derived APCs (i.e. eTACs and B cells), we have recently 
established a strain of NOD in which human AIRE (huAIRE) 
is additively expressed under the control of the MHC-II pro-
moter [huAIRE transgenic (huAIRE-Tg)] with the aim of ameli-
orating the autoimmune pathology in NOD (19). Paradoxically, 
however, huAIRE-Tg mice developed muscle-specific auto-
immunity that was associated with defects in both the thymic 
and peripheral tolerance mechanisms: mTECs expressing 
huAIRE showed defective maturation accompanied by re-
duced TRA expression, including Ins2. In peripheral B cells 
from huAIRE-Tg mice, expression of the co-stimulatory mol-
ecule CD86 was up-regulated. It was noteworthy that muscle-
specific autoimmunity developed only when both mTECs 
and BM-derived APCs expressed huAIRE at high levels, as 
revealed in BM chimeras (19). Thus, an altered capacity to 
present self-antigens in thymic and peripheral APCs manipu-
lated through additive huAIRE expression resulted in the de-
velopment of de novo muscle-specific autoimmunity.
In the present study, we focused on another effect of addi-
tive huAIRE expression on the development of T1D in NOD. 
We found that huAIRE-Tg had defective presentation of β-islet 
antigens in the periphery because of impaired development 
and/or function of a particular subset of DCs (i.e. Xcr1+ DCs), 
as a result of which the mice became resistant to the devel-
opment of T1D. In contrast to the situation in muscle-specific 
autoimmunity, mTECs expressing huAIRE had no major im-
pact on the production of diabetogenic T cells revealed by 
the BM chimeras. Thus, our results suggested that a distinct 
set of tissue-specific immune responses (i.e. against muscle 
or against β-islets) is positively or negatively controlled by 
the altered thymic and/or peripheral tolerance function upon 
introduction of huAIRE/Aire as a modifier of each tolerance 
mechanism. These results suggest that control of the tissue-
specific immune response may be feasible through manipu-
lation of the thymic and peripheral tolerance mechanisms by 




Mice expressing huAIRE under control of the MHC-II promoter 
were generated as reported previously (19). TCR transgenic 
(TCR-tg) mice NY8.3 (20) and BDC2.5 (21), and B-cell-
deficient NOD mice (22) were purchased from the Jackson 
Laboratory. NOD/ShiJic-scidJcl mice and Rag2-deficient 
mice were obtained from CLEA Japan Inc. and Taconic, re-
spectively. Mice were diagnosed as diabetic when blood glu-
cose levels exceeded 250 mg dl−1. The mice were maintained 
under pathogen-free conditions, and handled in accordance 
with the Guidelines for Animal Experimentation of Tokushima 
University School of Medicine.
Pathology
Formalin-fixed tissue sections were subjected to hematoxylin 
and eosin (H&E) staining, and two pathologists independ-
ently evaluated the histology without being informed of the 
detailed condition of each individual mouse.
TEC preparation and flow cytometric analysis
Preparation of TECs and flow cytometric analysis with a FACS-
calibur (BD) and a FACSAria II (BD) were performed as de-
scribed previously (19). In brief, thymic lobes were isolated 
from mice and cut into small pieces. The fragments were pip-
etted to remove the majority of thymocytes in RPMI 1640 me-
dium (Gibco) supplemented with 10% heat-inactivated fetal 
calf serum (FCS) (Bovogen), 20 mM HEPES, 50 U ml−1 peni-
cillin, 50 μg ml−1 streptomycin and 50 μM 2-mercaptoethanol, 
hereafter referred to as R10. The resulting thymic fragments 
were digested with 0.15% collagenase D (Roche) and 10 U 
ml−1 DNase I (Roche) in R10 at 37°C for 30 min. The super-
natants, containing dissociated TECs, were saved, and 
the remaining thymic fragments were digested with 0.15% 
collagenase/dispase (Roche) and DNase I at 37°C for 30 min. 
The supernatants from this digest were combined with the 
supernatants from the collagenase digests, and the mixture 
was centrifuged for 5  min at 400  × g. The cells were sus-
pended in phosphate-buffered saline (PBS) containing 5 mM 
ethylenediaminetetraacetic acid (EDTA) and 1% bovine serum 
albumin (BSA), and kept on ice until staining. The monoclonal 
antibodies (mAbs) used were anti-CD45, anti-Ly51, anti-CD80, 
anti-CD103, anti-CD8a, B220, anti-CD19, anti-CD11b, anti-
CD11c and F4/80, all purchased from eBioscience. Anti-
EpCAM and anti-Xcr1 mAbs were from BioLegend. Ulex 
europaeus agglutinin 1 (UEA-1) was from Vector Laboratories.
BM transfer
BM transfer was performed as described previously (19). In 
brief, BM cells were suspended in R10 medium containing 
anti-CD90 (Thy1.2) mAb (clone 30-H12; BioLegend) plus low-
toxicity rabbit complement (Cedarlane Laboratories). After in-
cubation at 37°C for 45 min, the cells were washed twice and 
adjusted to 5  × 107 viable cells ml−1 in R10 not containing 
FCS. Each recipient mouse was then lethally irradiated (9 Gy) 
and treated with 0.2 ml of donor BM cells i.v. on the same day.
Measurement of proliferation of TCR-Tg T cells specific for 
β-islet antigens
Spleen cell suspensions prepared from TCR-tg mouse strains 
NY8.3 and BDC2.5 were depleted of red blood cells by os-
motic lysis, and their T cells were purified by depletion with 
B220+ MicroBeads (Miltenyi Biotec). The resulting prepar-
ations contained approximately 95% T cells. The purified 
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NY8.3 CD8+ cells and BDC2.5 CD4+ cells were labeled with 
5- (and 6-)carboxyfluorescein diacetate succinimidyl ester 
(CFSE) (Dojindo), and injected i.v. (6.0–10.0 × 106 cells per 
mouse) into heterozygous 2m9L-Tg or control mice. Cell pro-
liferation was measured 64 h after T-cell transfer.
Transfer of peripheral T cells into NOD.scid mice
Spleen cell suspensions were depleted of red blood cells by 
osmotic lysis, and their Thy1+ cells were purified with CD90.2 
(Thy1.2) MicroBeads (Miltenyi Biotec). The resulting prepar-
ations contained approximately 95% Thy1+ cells. The puri-
fied Thy1+ cells were injected i.v. (1.0 × 107 cells per mouse), 
and development of diabetes was monitored for 20 weeks. 
Diagnosis of diabetes was performed as described above.
Flow cytometric analysis of BM-APCs from β-islets
β-islets from the pancreas were isolated as described pre-
viously (23, 24). Briefly, pancreata were inflated through the 
common bile duct with 5.0 ml of HBSS supplemented with 
380.0 μg ml−1 collagenase. The pancreata were then removed 
carefully and digested in a 37°C water bath for 13 min. After 
vigorous shaking for 90 s, the pancreata were washed three 
times in HBSS and passed through a 70-µm cell strainer to 
retain the islets. The islets were flushed into a Petri dish and 
handpicked using a pipette. For flow cytometric analysis, islet 
cells were dispersed using Cell Dissociation Solution Non-
Enzymatic (Sigma) for 3 min at 37°C.
Generation of BM-derived Xcr1+ DCs
BM cells were harvested by flushing the femurs of mice with 
R10. The cells were cultured in R10 containing 100 ng ml−1 
human Flt3L (Peprotech, London, UK) for 8  days as previ-
ously described (25). They were then stained with B220, 
anti-CD11c, anti-CD11b, anti-CD24 and anti-Xcr1 mAbs 
and B220−CD11c+CD11b+CD24+Xcr1+ cells were sorted by 
FACSAria II (BD) as Xcr1+ DCs for RNA-seq analysis.
Real-time PCR
RNA was extracted from TECs using RNeasy Mini Kits 
(Qiagen) and converted to cDNA with SuperScript III or VILO 
RT Kits (Invitrogen) in accordance with the manufacturer’s 
instructions. Real-time PCR for quantification of the insulin 
2 (Ins2), salivary protein 1 (Sap1) and Hprt genes was per-
formed as described previously (19). Detailed sequence in-
formation was provided in our previous paper (19).
RNA-seq analysis
RNA-seq analysis was performed as described previously 
(19). In brief, total RNAs from sorted DCs were isolated 
using an RNeasy Mini Kit (Qiagen) in accordance with the 
manufacturer’s instructions. Eluted RNAs were incubated with 
RT-grade DNase (Nippon Gene) for 10 min at room tempera-
ture, followed by purification on an RNeasy column (Qiagen). 
RNAs were verified both quantitatively and qualitatively 
using an Agilent RNA 6000 Pico Kit run on an Agilent 2100 
Bioanalyzer (Agilent Technologies). RNA Integrity Numbers 
were >7. Three independent biological replicates from each 
genotype were used for RNA-seq analysis. Sequencing li-
braries were generated from 1.0 ng of total RNA with Ovation 
SoLo RNA-Seq Systems (NuGEN). The libraries were size-
selected with AMPure XP beads (Agilent Technologies) and 
used for cluster generation on the flow cells. Single-end 150-bp 
sequencing was performed with an Illumina MiSeq (Illumina), 
which generated 5.8–20  × 106 sequenced fragments per 
sample. Prior to alignment, the reads were trimmed to remove 
adapter sequences. Reads were mapped to the mouse refer-
ence genome GRCm38/mm10 using the STAR aligner with the 
option: -outSAMtype BAM SortedByCoordinate to generate a 
sorted BAM format. Differential gene expression between the 
experimental samples was analyzed with Cufflinks. Read count 
tables and group comparisons for differential expression ana-
lysis were performed with Cuffdiff, which is part of the Cufflinks 
package. The false discovery rate (FDR) for detection of differ-
entially abundant transcripts was set to 5%. The data set asso-
ciated with this project has been submitted to DDBJ Sequence 
Reads Archive (DRA accession number: DRA006501).
Measurement of anti-keyhole limpet hemocyanin antibody 
response
Mice were i.p. injected with keyhole limpet hemocyanin (KLH) 
in complete Freund’s adjuvant, and sera were harvested 14 
and 21 days after immunization. Subclass-specific anti-KLH 
responses were measured by ELISA.
Statistical analysis
All results are expressed as mean ± SEM. The log-rank test 
was performed for Kaplan–Meier survival curves. Differences 
were considered significant at P <0.05.
Results
Acquisition of resistance to T1D in NOD through expression 
of huAIRE in BM-derived APCs
We have recently reported that transgenic mice additively 
expressing huAIRE under control of the MHC-II promoter on 
NOD (huAIRE-Tg) paradoxically developed muscle-specific 
autoimmunity in two independent lines out of three (i.e. lines 
2m9L-Tg and 1m4L-Tg, but not line 8L-Tg) (19): percentages 
of peripheral B cells expressing huAIRE were, in decreasing 
order, 2m9L-Tg > 1m4L-Tg > 8L-Tg (Fig. 1A). This corres-
ponded to the order of huAIRE expression levels in mTECs (19). 
Interestingly, only half of the MHC-II-positive B220+ splenic B 
cells expressed huAIRE, and the rest did not (Supplementary 
Figure 1, top). Of note, there was a correlation between the ex-
pression of CD86, but not CD80, and huAIRE within B220+ B 
cells (Supplementary Figure 1, middle and bottom), suggesting 
that expression of MHC-II may not be sufficient for huAIRE ex-
pression. Instead, some other cellular condition such as ac-
tivation status may control huAIRE expression at the protein 
level. Although muscle-specific autoimmunity appeared only 
when the transgene was homozygous, but not heterozygous, 
for both 2m9L-Tg and 1m4L-Tg, we were able to obtain genetic 
evidence indicating that this phenotype was attributable to the 
gene-dosage effect of huAIRE, and not to the inserted muta-
tions. Indeed, 2m9L-Tg (high line) and 1m4L-Tg (intermediate 
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line) developed the disease in 100% and ~20% of individuals, 
respectively, in the homozygous state (19). In that study, we 
also confirmed the competence of huAIRE protein in mice by 
crossing huAIRE-Tg onto Aire-deficient mice (Aire-KO), and 
observed rescue from the autoimmune lethality caused by Aire 
deficiency on a NOD background (26). RNA-seq analysis also 
showed that huAIRE expression in mTECs abolished the differ-
ential expression of genes appearing between Aire-sufficient 
and Aire-deficient mTECs, thus clearly indicating that huAIRE 
is functional in mice (19).
Monitoring of blood glucose levels showed that 2m9L-Tg 
had complete resistance to the development of T1D when 
the transgene was heterozygous (+/Tg) (n > 50)  (Fig. 1B) 
(19): these mice showed no pancreatic pathology, in marked 
contrast to their non-Tg littermates (Fig. 1C). In contrast to 
2m9L-Tg (high line), 1m4L-Tg (intermediate line) and 8L-Tg 
(low line) developed T1D when the transgene was heterozy-
gous [55.6% in 1m4L-Tg (n = 9); 75.0% in 8L-Tg (n = 4); 71.7% 
in non-Tg (n = 46)] (Fig. 1B). In order to investigate which cell 
types expressing huAIRE [i.e. stromal component (mTECs) 
Fig. 1. Expression of huAIRE in BM-derived APCs renders NOD resistant to the development of T1D. (A) Detection of peripheral B cells 
(CD19+CD3−) expressing huAIRE in huAIRE-Tg lines using flow cytometric analysis (left). A summary of the results is shown on the right. One 
circle corresponds to one mouse analyzed. (B) Female heterozygous 2m9L-Tg showed complete resistance to the development of T1D (n > 
50), whereas female mice from two other lines developed T1D when the cumulative incidence of T1D was monitored until 40 weeks of age 
[55.6% in 1m4L-Tg (n = 9); 75.0% in 8L-Tg (n = 4); 71.7% in non-Tg (n = 46)]. (C) Pancreatic pathology of heterozygous 2m9L-Tg and non-Tg 
littermates. One representative result from a total of more than five experiments is shown. Scale bar: 100 µm. (D) Development of T1D in recip-
rocal BM chimeras using heterozygous 2m9L-Tg. Cumulative incidence of T1D was monitored until 40 weeks of age: non-Tg into non-Tg, n = 8; 
non-Tg into +/Tg, n = 6; +/Tg into non-Tg, n = 7. (E) Resistance to T1D in BM chimeras that had received BM cells from homozygous 2m9L-Tg. 
non-Tg into non-Tg, n = 4; Tg/Tg into non-Tg, n = 4.
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or BM-derived APCs such as B cells (Fig. 1A) and DCs] are 
responsible for the acquisition of the resistance to T1D in het-
erozygous 2m9L-Tg, we performed reciprocal BM transfer 
experiments. Non-Tg (NOD) that received BM cells from het-
erozygous 2m9L-Tg showed resistance to T1D as untreated 
heterozygous 2m9L-Tg (Fig. 1D), suggesting that BM-derived 
cells expressing huAIRE are responsible for the resistance to 
T1D. Conversely, heterozygous 2m9L-Tg receiving BM cells 
from non-Tg, albeit with a slightly lower incidence, devel-
oped T1D similarly to non-Tg that had received non-Tg BM 
cells, suggesting that huAIRE expression in mTECs had no 
major impact on the production of diabetogenic T cells in the 
thymus (Fig. 1D). The latter finding was rather unexpected 
because RNA-seq analysis showed that, in heterozygous 
2m9L-Tg, the expression level of Ins2, a primary autoantigen 
in NOD (7), by mTECs was one-third of that in wild-type (WT) 
NOD [WT = 3.169 reads per kilo base pair of exon per mil-
lion mapped sequence reads (RPKM) versus +/Tg = 1.003 
RPKM]. Because all homozygous 2m9L-Tg die before 25 
weeks of age due to severe muscle pathology (19), we were 
unable to carry out sufficiently long-term observations to de-
termine whether homozygous 2m9L-Tg were also resistant 
to T1D. However, when BM cells from homozygous 2m9L-Tg 
were transferred into non-Tg, we found that those chimeras 
were resistant to T1D (Fig. 1E), strongly suggesting that un-
treated homozygous 2m9L-Tg might also be resistant to T1D 
if they were capable of surviving long enough for completion 
of diabetogenesis. Thus, opposite effects on autoimmunity 
(i.e. development of muscle-specific autoimmunity versus 
amelioration of T1D) were observed within the same homozy-
gous 2m9L-Tg individual.
Defective presentation of β-islet antigens by peripheral 
APCs accounts for resistance to T1D in huAIRE-Tg
During the course of diabetogenesis, T cells generated in 
the thymus must become activated by recognizing β-islet 
antigens presented by peripheral APCs for autoimmune at-
tack against β-islets. From the BM transfer experiments (Fig. 
1D), we suspected that presentation of β-islet antigens by 
peripheral BM-derived APCs might be defective in 2m9L-Tg. 
To test this possibility, we utilized T cells from two types of 
TCR transgenic mice, NY8.3 (20) and BDC2.5 (21). NY8.3 
CD8+ T cells and BDC2.5 CD4+ T cells are specific for islet-
specific glucose-6-phosphatase catalytic subunit-related 
protein (IGRP) (20) and hybrid peptides resulting from fu-
sion between chromogranin A and insulin (27), respectively. 
When CFSE-labeled NY8.3 CD8+ T cells were transferred into 
non-Tg (NOD), we observed active proliferation of NY8.3 CD8+ 
T cells in the pancreatic LNs and pancreas, but not in inguinal 
LNs (Fig. 2A, left panels), suggesting that BM-derived APCs 
presenting the β-islet antigen IGRP were present in the pan-
creatic LNs and pancreas but not in inguinal LNs. This con-
trasts with the presentation of insulin peptide that occurs in 
LNs throughout the body (4). In contrast, NY8.3 CD8+ T cells 
transferred into heterozygous 2m9L-Tg showed significantly 
reduced proliferation in the pancreatic LNs and pancreas 
(Fig. 2A, right panels). Thus, presentation of β-islet antigens 
(IGRP) coupled with MHC-I to potentially diabetogenic CD8+ 
T cells was defective in 2m9L-Tg. NY8.3-Tg (NOD) have 
been reported to develop diabetes relatively earlier than 
non-Tg NOD mice (28). Indeed, three out of six NY8.3-Tg de-
veloped diabetes during the observation period of 8 weeks 
after birth. In contrast, when NY8.3-Tg were crossed with 
2m9L-Tg, none out of seven developed diabetes during the 
same period (Minoru Matsumoto, Mitsuru Matsumoto and 
H.  Nishijima, unpublished observation), which is consistent 
with the lack of proliferation of transferred NY8.3 CD8+ T 
cells in the pancreatic LNs and pancreas in heterozygous 
2m9L-Tg (Fig. 2A). Transfer of BDC2.5 CD4+ T cells into het-
erozygous 2m9L-Tg also reduced the proliferation of BDC2.5 
CD4+ T cells in pancreatic LNs relative to that in non-Tg (Fig. 
2B). In this case, detection of BDC2.5 CD4+ T cells in the 
pancreas was difficult in heterozygous 2m9L-Tg, in contrast 
to non-Tg, possibly because of the poor antigenic stimulation 
of BDC2.5 CD4+ T cells in the pancreatic LNs. Thus, pres-
entation of β-islet antigens (peptides that are hybrid forms 
between chromogranin A and insulin) complexed with MHC-II 
by peripheral APCs was also defective in 2m9L-Tg, together 
contributing to T1D resistance.
The defective presentation of β-islet antigens by periph-
eral APCs in 2m9L-Tg was further confirmed by transferring 
diabetogenic T cells into lymphopenic hosts. For this pur-
pose, we generated Rag2-deficient heterozygous 2m9L-Tg 
to allow homeostatic expansion of diabetogenic T cells in 
the hosts. Diabetogenic T cells were harvested from the 
spleens of pre-diabetic NOD, and then transferred into Rag2-
deficient non-Tg or Rag2-deficient heterozygous 2m9L-Tg 
recipients both on a NOD background. We found that all the 
Rag2-deficient non-Tg mice became diabetic after injection 
of diabetogenic T cells, as expected (Fig. 2C). In contrast, 
none of the Rag2-deficient heterozygous and homozygous 
2m9L-Tg hosts developed T1D after this treatment. These re-
sults supported our notion that diabetogenic T cells were not 
activated by peripheral APCs to cause T1D in 2m9L-Tg.
BM-derived APCs other than B cells from huAIRE-Tg are 
responsible for defective presentation of β-islet antigens
Because B cells in our huAIRE-Tg mice expressed huAIRE 
(Fig. 1A), and B cells have been suggested to play a role 
in diabetogenesis in NOD (22, 29), we examined whether B 
cells are involved in the acquisition of resistance to T1D by 
crossing heterozygous 2m9L-Tg onto B-cell-deficient mice 
(Ighm-KO) on a NOD background (22). We found that none 
out of 18 female Ighm-KO/heterozygous 2m9L-Tg developed 
T1D, whereas control Ighm-KO developed T1D (Fig. 3A). The 
results suggested that B cells were irrelevant to this pheno-
type, and that BM-derived APCs expressing huAIRE other 
than B cells were responsible for the T1D resistance in het-
erozygous 2m9L-Tg.
We evaluated the transgenic huAIRE expression in DCs 
from heterozygous 2m9L-Tg using flow cytometry, and found 
that CD45+CD11c+F4/80−MHC-IIhigh DCs isolated from the 
spleen, thymus, and inguinal and pancreatic LNs expressed 
huAIRE (Fig. 3B): we noticed that not all of the MHC-IIhigh DCs 
expressed huAIRE, as we had observed for B cells as de-
scribed above (Fig. 1A). We assume that some other fac-
tors beyond the MHC-II level allow DCs to express huAIRE 
at the protein level. The expression levels of huAIRE in DCs 
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from heterozygous 2m9L-Tg detected by real-time PCR were 
higher than those in mTECs from Aire-reporter mice in which 
a fusion gene of huAIRE and GFP was knocked-in at the Aire 
locus [Aire/huAIRE-GFP-Flag knock-in (AGF-KI) (30)] (Fig. 
3C, left). It has been reported that endogenous Aire expres-
sion by DCs is difficult to detect by flow cytometric analysis 
(31). However, real-time PCR analysis demonstrated Aire ex-
pression in DCs from both non-Tg controls and heterozygous 
2m9L-Tg, albeit at much lower levels than those in mTECs 
(Fig. 3C, right). Given that peripheral BM-derived APCs from 
2m9L-Tg are defective in the presentation of β-islet antigens, 
it was assumed that the presence of normal BM-derived APCs 
other than B cells should cancel the phenotype of resistance 
to T1D in 2m9L-Tg. We tested this idea by co-transferring BM 
cells from B-cell-deficient heterozygous 2m9L-Tg together 
with BM cells from non-Tg NOD.scid into non-Tg (NOD): BM 
Fig. 2. Defective presentation of β-islet antigens accounts for resistance to T1D in huAIRE-Tg. (A) Reduced proliferation of transferred NY8.3 
CD8+ T cells in the pancreatic LNs (pLNs) and pancreas of heterozygous 2m9L-Tg. CFSE-labeled NY8.3 CD8+ T cells isolated from the spleen 
were i.v.-injected into non-Tg or heterozygous 2m9L-Tg. Sixty-four hours later, division of NY8.3 CD8+ T cells isolated from inguinal LNs (iLN), 
pLNs and the pancreas was assessed by flow cytometric analysis. One representative experiment from a total of two repeats is shown. (B) 
Reduced proliferation of transferred BDC2.5 CD4+ T cells in the pLNs, and dramatically reduced numbers of BDC2.5 CD4+ T cells in the pan-
creas of heterozygous 2m9L-Tg. CFSE-labeled BDC2.5 CD4+ T cells isolated from the spleen were i.v.-injected into non-Tg or heterozygous 
2m9L-Tg. Sixty-four hours later, division of BDC2.5 CD4+ T cells isolated from iLNs, pLNs and the pancreas was assessed by flow cytometric 
analysis. One representative experiment from a total of two repeats is shown. (C) Splenic T cells isolated from pre-diabetic NOD at 15–18 weeks 
of age were i.v.-injected into Rag2-deficient non-Tg (n = 6), Rag2-deficient heterozygous 2m9L-Tg (+/Tg; n = 5) or Rag2-deficient homozygous 
2m9L-Tg (Tg/Tg/; n = 3). Mice were then monitored for the development of T1D.
122 Amelioration of diabetes in NOD by additive Aire
Fig. 3. DCs but not B cells from huAIRE-Tg are responsible for defective presentation of β-islet antigens. (A) Development of T1D in female 
B-cell-deficient NOD (Ighm-KO) (n = 6) and B-cell-deficient heterozygous 2m9L-Tg (Ighm-KO/heterozygous 2m9L-Tg) (n = 18). (B) Expression 
of huAIRE in CD45+CD11c+F4/80− DCs in spleen, thymus, iLNs and pLNs from heterozygous 2m9L-Tg. One representative experiment from a 
total of three repeats is shown. (C) Expression levels of huAIRE in DCs were compared with those in mTECs from Aire-reporter mice expressing 
the fusion gene of huAIRE, GFP and Flag (Aire/AGF-KI) (30)] (left). Expression of endogenous Aire from DCs and mTECs was determined by 
real-time PCR (right). The expression level of Hprt served as an internal control for RNAs. One representative experiment from a total of two 
repeats is shown. (D) BM cells isolated from B-cell-deficient heterozygous 2m9L-Tg and from NOD.scid were mixed together at a 1:1 ratio, and 
then transferred into non-Tg (NOD) (blue circle, n = 6). As a control, non-Tg receiving BM cells from B-cell-deficient heterozygous 2m9L-Tg (red 
square, n = 8) and non-Tg receiving BM cells from non-Tg (white circle, n = 5) were prepared. Mice were then monitored for the development 
of T1D.
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cells from non-Tg NOD.scid provide WT DCs but not any 
T/B cells. Strikingly, all but one of the six mice receiving this 
treatment developed T1D (Fig. 3D): the single non-diabetic 
recipient also showed marked lymphoid cell infiltration 
into β-islets (Minoru Matsumoto, Mitsuru Matsumoto and 
H.  Nishijima, unpublished observation). In contrast, non-Tg 
hosts receiving BM cells from B-cell-deficient heterozygous 
2m9L-Tg alone showed resistance to the development of T1D 
(Fig. 3D), further supporting the idea that B cells expressing 
huAIRE were irrelevant to the T1D resistance revealed by 
the mouse crossing experiments (Fig. 3A). Non-Tg hosts re-
ceiving BM cells from non-Tg developed T1D, as expected. 
Thus, expression of huAIRE in peripheral BM-derived APCs, 
most likely DCs, was responsible for the defective presen-
tation of β-islet antigens that is critical for the diabetogenic 
process in NOD.
Of note, BM-derived APCs from 2m9L-Tg did not show de-
fective antigen presentation overall. Rather, defective presen-
tation was confined to β-islet antigens because homozygous 
2m9L-Tg are able to present muscle antigens for the devel-
opment of muscle-specific autoimmunity (19). Furthermore, 
immunization with an exogenous antigen of KLH elicited 
anti-KLH antibody responses equally well in heterozygous 
2m9L-Tg, as seen in non-Tg littermates (Supplementary 
Figure 2).
Effect of huAIRE expression on development of Xcr1+ DCs
It has been reported that pancreatic β-islets in young NOD 
(i.e. ~ 3 weeks of age) contain two sets of APCs: a major 
population of macrophages and a minor population of 
CD8α +CD103+ DCs (equivalent to Xcr1+ DCs) (23, 24), both 
populations being indispensable for the development of T1D 
in NOD (15). Interestingly, macrophages residing in β-islets 
have the capacity to present β-islet antigens, and play an 
initiating role in communication with diabetogenic T cells (24, 
32). To investigate whether APCs in β-islets from 2m9L-Tg 
show this initial manifestation, we isolated pancreatic islets 
from 3-week-old heterozygous 2m9L-Tg and examined their 
APC composition. We found that these β-islets contained 
CD11cintermediate-highCD11b+F4/80+Xcr1− macrophages similar in 
percentages to those from non-Tg (Fig. 4A), suggesting that 
the initial event involving the macrophages was not affected 
by the expression of huAIRE in MHC-II+ BM-derived APCs.
A transcription factor Batf3 controls the differentiation of a 
subset of Xcr1+ DCs (CD8α +CD103+ DCs) in mice (33) and 
regulates the development of T1D in NOD (23). We exam-
ined Xcr1+ DCs in heterozygous 2m9L-Tg, and found that 
the percentages of Xcr1+ DCs were significantly reduced in 
the spleen, thymus and pancreatic LNs compared with those 
from non-Tg controls (Fig. 4B). Importantly, the degree of 
reduction of Xcr1+ DCs was correlated with the expression 
level of huAIRE: heterozygous 1m4L-Tg (intermediate line) 
demonstrated a milder reduction of Xcr1+ DCs in pancre-
atic LNs relative to heterozygous 2m9L-Tg (high line) (Fig. 
4C). Furthermore, homozygous 1m4L-Tg (Tg/Tg) showed a 
more severe reduction of Xcr1+ DCs relative to heterozygous 
1m4L-Tg (+/Tg), although the degree of reduction evident 
in homozygous 1m4L-Tg (Tg/Tg) was still milder than that 
shown by heterozygous 2m9L-Tg (+/Tg) (Fig. 4C).
We confirmed the effect of huAIRE expression in DCs 
on the production of Xcr1+ DCs by expanding CD11c+ 
DCs from BM cells in vitro: we cultured BM cells from 
wild-type WT NOD with FLT3 ligand for 8  days, and 
classified the viable cells into three major populations 
(Fig. 5A, top) (25): B220+CD11blow plasmacytoid DCs 
(pDCs), B220−CD11b+CD24− DCs (CD11b+ DCs) and 
B220−CD11b+CD24+ DCs: the third population expressed 
Xcr1 (Xcr1+ DCs) (Fig. 5A, top right). The percentages and 
absolute numbers of in vitro-expanded Xcr1+ DCs were re-
duced in heterozygous 2m9L-Tg and, to a lesser extent, in 
heterozygous 1m4L-Tg compared with those from non-Tg 
mice (Fig. 5A and B). Expression levels of Xcr1 were also 
reduced in heterozygous 2m9L-Tg (Fig. 5A, middle right). 
In contrast, pDCs in huAIRE-Tg were indistinguishable from 
those in non-Tg mice (Fig. 5B). Percentages of CD11b+ DCs 
showed a relative increase in huAIRE-Tg because of the re-
duced percentages of Xcr1+ DCs (Fig. 5B, upper), although 
the absolute numbers of CD11b+ DCs remained unchanged 
(Fig. 5B, lower). Thus, Xcr1+ DCs generated from BM cells 
with FLT3 ligand mirrored the development of Xcr1+ DCs in 
vivo (Fig. 4C). We evaluated the expression of huAIRE in 
in vitro-expanded DCs, and found that CD11b+ DCs and 
Xcr1+ DCs, but not pDCs, expressed huAIRE (Fig. 5C): both 
CD11b+ DCs and Xcr1+ DCs from heterozygous 2m9L-Tg 
expressed higher levels of huAIRE than those from hetero-
zygous 1m4L-Tg. Taken together, these results suggested 
that production of Xcr1+ DCs, a crucial DC population for 
the development of T1D (23), was negatively regulated by 
huAIRE in a dose-dependent manner.
Alterations of the production and transcriptome of Xcr1+ 
DCs account for resistance to T1D
Given that only the 2m9L-Tg line, which showed highest 
huAIRE expression and most severe reduction of Xcr1+ DCs 
among the three lines, acquired the resistance to T1D, we 
suspected that the degree of the reduction of Xcr1+ DCs 
is crucial for T1D resistance. We tested this idea by moni-
toring the development of T1D in 1m4L-Tg, heterozygous 
(+/Tg) individuals of which were susceptible to T1D (Fig. 
1B) and homozygous (Tg/Tg) individuals of which showed 
more severe reduction of Xcr1+ DCs than heterozygous 
1m4L-Tg (Fig. 4C). Most of the heterozygous 1m4L-Tg 
showed pathological changes in β-islets (Fig. 5D and E), 
and in fact more than half of the heterozygous 1m4L-Tg de-
veloped T1D (Fig. 1B). Strikingly, none of the homozygous 
1m4L-Tg developed T1D (n > 8), and consequently showed 
significantly milder pathological changes in the β-islets 
(Fig. 5D and E). Thus, negative dose-dependent control of 
the number of Xcr1+ DCs through expression of huAIRE is a 
critical determinant of T1D development. We suggest that a 
certain number of Xcr1+ DCs in pancreatic LNs and/or the 
pancreas is necessary in order to elicit an autoimmune re-
sponse against β-islets.
Although the reduced numbers of Xcr1+ DCs in pancreatic 
LNs might largely account for the defect in the presentation 
of β-islet antigens, and consequently for the resistance to 
T1D in huAIRE-Tg, we also wanted to evaluate transcriptomic 
changes in the remaining Xcr1+ DCs in heterozygous 
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Fig. 4. Reduced numbers and altered function of Xcr1+ DCs in huAIRE-Tg. (A) Macrophages residing within β-islets were examined by flow 
cytometric analysis after isolating β-islets from heterozygous 2m9L-Tg at 3 weeks of age. Samples were gated for CD45+MHC-II+ cells. One 
representative experiment from a total of four repeats is shown. (B) Reduced numbers of Xcr1+ DCs in the spleen, thymus and pancreatic LNs 
(pLN) from heterozygous 2m9L-Tg compared with those from control littermates (left). Cells were gated for the CD45+CD11c+F4/80−MHC-II+ 
population. A summary of the results is shown on the right. One circle corresponds to one mouse analyzed. **P < 0.01. (C) Reduced percent-
ages of Xcr1+ DCs in pLNs from heterozygous 2m9L-Tg, heterozygous 1m4L-Tg (+/Tg) and homozygous 1m4L-Tg (Tg/Tg) as analyzed in B 
(left). A summary of the results is shown on the right. One circle corresponds to one mouse analyzed. **P < 0.01; *P < 0.05.
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Fig. 5. BM-derived DCs expanded from huAIRE-Tg in vitro reflect the developmental signature of DCs in vivo and diabetogenic pathology. (A) 
Three populations including pDCs (B220+CD11blow), CD11b+ DCs (B220−CD11b+CD24−) and Xcr1+ DCs (B220−CD11b+CD24+) were induced 
by treatment with BM cells from non-Tg, heterozygous 2m9L-Tg and heterozygous 1m4L-Tg with Flt3L. Expression of Xcr1 from each population 
(pDC, green line; CD11b+ DC, blue line; Xcr1+ DC, red line) is shown on the right. (B) A summary of the results in (A) is shown. The percentages 
(upper) and absolute numbers of Xcr1+ DCs (lower) were reduced in heterozygous 2m9L-Tg and, to a lesser extent, in heterozygous 1m4L-Tg. 
**P < 0.01; *P < 0.05. (C) Expression of huAIRE from in vitro-expanded DC populations was evaluated by flow cytometric analysis. One rep-
resentative experiment from a total of two repeats is shown. (D) All the heterozygous 1m4L-Tg (n = 10) but one showed pathological changes 
in β-islets, whereas homozygous 1m4L-Tg showed significantly milder pathological changes (n = 8) compared with those from heterozygous 
1m4L-Tg. Pathological changes in the pancreas were evaluated with H&E staining without being informed of the detailed condition of the indi-
vidual mice. White column, no pathological change; half-filled column, peri-insulitis and/or peri-vasculitis; full-filled column, massive insulitis. M, 
male: F, female. All the mice were 7.5–8 months old. Mice shown in (E) are marked with asterisks. (E) Two representative examples (one female 
and one male) of histology from heterozygous and homozygous 1m4L-Tg summarized in (D) are shown. Scale bar: 100 µm.
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2m9L-Tg. Because the low numbers of Xcr1+ DCs in pancre-
atic LNs did not allow us to directly examine the transcrip-
tome of this subset, we utilized Xcr1+ DCs expanded from BM 
cells in vitro as described above. We obtained the data using 
triplicate samples from heterozygous 2m9L-Tg and control 
mice, and set FDR q <0.05 as the level of significance. We 
found that 38 genes were up-regulated whereas 15 genes 
were down-regulated in BM-derived Xcr1+ DCs from het-
erozygous 2m9L-Tg (Fig. 6A from DRA006501). The down-
regulated genes included C-type lectins such as CD207 
(Langerin) and CD209a (DC-SIGN), which are implicated in 
the development of T1D: NOD showed a decreased number 
of CD8+CD103+CD207+ DCs in the pancreas (34). It has been 
reported that CD209a polymorphisms are associated with the 
development of T1D in humans (35). Because we have per-
formed RNA-seq analysis using in vitro-expanded Xcr1+ DCs 
from BM, expression levels of Xcr1 and Batf3 remained un-
changed in this analysis (Supplementary Figure 3). Of note, 
key factors that control the development of Xcr1+ DCs such 
as Irf8, Id2 and Nfil3 (36) also remained unchanged by the 
expression of huAIRE.
Although enforced expression of Aire in many cell types 
both in vitro (37, 38) and in vivo (39, 40) has been reported 
to induce ectopic expression of TRAs, neither B cells (19) nor 
DCs isolated from pancreatic LNs of heterozygous 2m9L-Tg 
expressed prototypic Aire-dependent TRAs (e.g. Ins2 and 
Sap1) in real-time PCR, in contrast to mTECs from non-Tg 
(Fig. 6B). Similarly, in vitro-expanded Xcr1+ DCs from both 
heterozygous 2m9L-Tg and 1m4L-Tg showed no Ins2 ex-
pression, as was the case for those from non-Tg (Fig. 6C). 
Taken together, these results suggest that reduced numbers 
of Xcr1+ DCs together with altered function of this subset 
caused by additive huAIRE expression are responsible for 
T1D resistance in huAIRE-Tg.
Maintenance of the diabetogenic T-cell pool requires 
continuous presentation of β-islet antigens in the 
periphery
Our data demonstrated that diabetogenic T cells were gener-
ated in the thymus from huAIRE-Tg as revealed by BM transfer 
experiments (Fig. 1D). However, these potentially harmful 
diabetogenic T cells did not attack β-islets because of the im-
paired development and/or function of Xcr1+ DCs that act in 
the periphery. We then investigated whether a diabetogenic 
T-cell pool is maintained in huAIRE-Tg in the absence of per-
ipheral presentation of β-islet antigens. For this purpose, we 
transferred splenic T cells isolated from non-Tg (NOD) or het-
erozygous 2m9L-Tg into NOD.scid. In this case, peripheral 
APCs in the hosts (NOD.scid) can present β-islet antigens 
to the transferred diabetogenic T cells. As expected, splenic 
T cells isolated from non-Tg induced T1D in NOD.scid hosts 
(Fig. 7). In contrast, splenic T cells isolated from heterozy-
gous 2m9L-Tg did not induce T1D in any hosts. Thus, in order 
for autoreactive T cells that have escaped thymic selection 
to induce T1D, they must be maintained in certain num-
bers and/or in a non-anergic state by continuous interaction 
with autoantigens presented in the periphery. These results 
suggest that it may be possible to prevent tissue-specific 
autoimmunity by attenuating the presentation of the corres-
ponding autoantigens through manipulation of DC develop-
ment via huAIRE/Aire expression.
Discussion
In the present study, we have demonstrated that additive 
huAIRE expression in BM-derived APCs, but not in mTECs, 
rendered NOD mice resistant to T1D. This was because of 
defective activation of autoreactive T cells specific for β-islet 
antigens in the periphery caused by altered development 
Fig. 6. Gene expression profiles from BM-derived DCs and pancreatic LNs in huAIRE-Tg. (A) Gene expression in in vitro-expanded Xcr1+ DCs 
from heterozygous 2m9L-Tg versus that from non-Tg, showing the 38 up-regulated genes and 15 down-regulated genes (colored). CD207 
(Langerin) and CD209a (DC-SIGN) are highlighted in blue. Data were obtained from triplicate samples from each group of cells, and FDR q 
<0.05 was defined as significant. (B) Expression of Ins2 and Sap1 in DCs isolated from pancreatic LNs of heterozygous 2m9L-Tg was assessed 
by real-time PCR. The expression level of Hprt was used as an internal control for RNAs. RNAs from mTECs of non-Tg served as a positive 
control. One representative experiment from a total of two repeats is shown. N.D., not detected. (C) No expression of Ins2 in in vitro-expanded 
DCs from heterozygous 2m9L-Tg and 1m4L-Tg revealed by real-time PCR. RNAs from mTECs of non-Tg served as a positive control. One rep-
resentative experiment from a total of four repeats is shown.
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and/or function of Xcr1+ DCs. There was an inverse correl-
ation between the level of huAIRE expressed and the Xcr1+ 
DCs produced: the more huAIRE in BM-derived APCs, 
the lower the production of Xcr1+ DCs. Accordingly, only 
2m9L-Tg, the highest-expressing huAIRE-Tg strain among 
the three with most severely reduced Xcr1+ DCs, showed 
resistance to T1D in a heterozygous state. However, when 
heterozygous 1m4L-Tg were bred onto their homozygous 
counterparts, mice resistant to T1D were produced, sug-
gesting a negative gene-dosage effect of huAIRE on pro-
duction of Xcr1+ DCs and T1D susceptibility. In contrast to 
the diabetogenic process described above, expression of 
huAIRE both in mTECs and BM-derived APCs was respon-
sible for the development of muscle-specific autoimmunity 
(19). This process was also dependent on the dose of 
huAIRE: the more huAIRE in mTECs and BM-derived APCs, 
the more frequent the appearance of muscle-specific auto-
immunity, as reflected in the fact that homozygous 2m9L-Tg 
and homozygous 1m4L-Tg developed muscle-specific auto-
immunity in 100% and ~20% of individuals, respectively (19). 
Thus, tissue-specific autoimmunity was controlled by the 
types of APCs that express huAIRE together with the dose of 
huAIRE expressed in our model.
Development of muscle-specific autoimmunity and preven-
tion of T1D occurred simultaneously in homozygous 2m9L-Tg, 
since BM-derived APCs from homozygous 2m9L-Tg rendered 
NOD resistant to T1D (Fig. 1E). Of note, this kind of ambiva-
lence in the tissue-specific immune response is not confined 
to the transgenic expression of huAIRE demonstrated in 
the present study. In fact, we have reported previously that 
deletion of endogenous Aire also resulted in a similar am-
bivalent outcome: in NOD lacking Aire, autoimmune attack 
against pancreatic β-islets was completely abrogated, ren-
dering them resistant to T1D, while de novo autoimmune 
attack against exocrine acinar cells developed (26). Thus, 
manipulation of Aire’s activity, either by additive huAIRE ex-
pression or by disruption of endogenous Aire, elicited similar 
ambivalence in the tissue-specific immune response. Clearly, 
therefore, further studies of autoimmunity control through me-
diation of huAIRE/Aire activity in tolerance mechanisms are 
warranted.
BM-derived APCs from both heterozygous and homozy-
gous 2m9L-Tg did not present β-islet antigens to elicit T1D 
because of reduced numbers and/or altered function of Xcr1+ 
DCs, whereas BM-derived APCs from homozygous 2m9L-Tg 
presented muscle antigens to induce the muscle-specific 
immune response. Given that Xcr1+ DCs play an important 
role in the presentation of antigens transferred from other 
cells (41) and that transfer of insulin granules from β-islets to 
Xcr1+ DCs is a critical step for the diabetogenic process in 
NOD (42), Xcr1+ DCs play an indispensable role in the pres-
entation of β-islet antigens to elicit T1D in the pancreas while 
other DC subsets can present muscle antigens to induce 
muscle-specific autoimmunity. Thus, we speculate that DC 
subsets involved in the induction of T1D and muscle-specific 
autoimmunity might be distinct in homozygous 2m9L-Tg. 
The involvement of distinct types of BM-derived APCs in 
the pathogenesis of tissue-specific autoimmunity was also 
manifested in the requirement of another BM-derived APC 
of B cells: B cells were irrelevant to acquisition of T1D re-
sistance in heterozygous 2m9L-Tg, whereas muscle-specific 
autoimmunity was markedly improved when B cells were de-
pleted from homozygous 2m9L-Tg (19).
Although expression of AIRE/Aire in DCs has been re-
ported in both mice and humans, the precise roles of AIRE/
Aire-expressing DCs in the immune response need to be fur-
ther studied (43, 44). In this regard, one recent report has 
indicated that AIRE in DCs has no major impact on the ex-
pression of TRAs from DCs (45), in contrast to the AIRE in 
mTECs, suggesting that some other role of AIRE may exist, 
such as immune defense against Candida albicans (46). So 
far, to our knowledge, a role of AIRE/Aire in the lineage spe-
cification of DCs has not been reported. Interestingly, like 
Batf3-deficient mice (41), generation of DC subsets other 
than Xcr1+ DCs (i.e. pDCs and CD11b+ DCs) was not af-
fected in huAIRE-Tg. The mechanism whereby a lack of Batf3 
or additive huAIRE expression in DCs results in reduction of 
a particular subset of Xcr1+ DCs remains unknown. Several 
other transcription factors beyond Batf3, including Irf8, Id2 
and Nfil3, have been reported to control the development of 
Xcr1+ DCs (36). Our transcriptomic analysis of BM-derived 
Xcr1+ DCs from heterozygous 2m9L-Tg revealed no major 
Fig. 7. Autoreactivity is maintained by continuous presentation of autoantigens in the periphery. Splenic T cells isolated from non-Tg, but not 
from heterozygous 2m9L-Tg, induced T1D when transferred into NOD.scid hosts. T cells from non-Tg into NOD.scid, n = 5; T cells from het-
erozygous 2m9L-Tg into NOD.scid, n = 5.
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alterations in the expression levels of these key factors (Fig. 
6A and Supplementary Figure 3), suggesting that huAIRE ex-
pression in DC precursors has an impact distinct from these 
transcription factors on the developmental program of DCs. 
The precise mechanism underlying the alteration of Xcr1+ 
DC development by additive huAIRE expression requires 
further study.
Kulshrestha and colleagues have reported that NOD mice 
that express mouse Aire under the control of the CD11c pro-
moter (CD11c-Aire Tg) exhibited delayed onset and reduced 
incidence of T1D in comparison with non-Tg littermates (40). 
However, the degree of resistance to T1D in CD11c-Aire Tg 
was less prominent than that shown by our huAIRE-Tg: the 
cumulative incidence of diabetes was reported to be ap-
proximately 80% in non-Tg versus 50% in CD11c-Aire Tg 
when assessed at 40 weeks of age. Although the studies re-
ported by Kulshrestha and our group both concluded that 
DCs transgenically expressing mouse Aire and huAIRE, re-
spectively, were responsible for the acquisition of T1D resist-
ance, there was a striking difference in the mechanisms to 
which those transgenic DCs contributed. Kulshrestha and 
colleagues found that DCs from CD11c-Aire Tg acquired 
the ability to express β-islet antigens including both Aire-
dependent (i.e. Ins2) and Aire-independent (i.e. Gad67) 
TRAs. They reported that those ectopically expressed β-islet 
antigens in DCs actively induced ‘exhausted’ populations of 
CD4+ and CD8+ T cells in an antigen-specific manner (40). 
In marked contrast to these findings, our studies demon-
strated that expression of huAIRE resulted in reduction of 
Xcr1+ DCs, thereby rendering them unable to present β-islet 
antigens to activate diabetogenic T cells in the pancreas 
and/or pancreatic LNs. This idea was confirmed by the fact 
that a co-population of BM-derived APCs from heterozygous 
2m9L-Tg with WT DCs from NOD.scid in non-Tg recipients in-
duced T1D. Furthermore, we did not observe any expression 
of Ins2 by DCs expressing huAIRE (Fig. 6B and C). The use 
of different species of Aire (mouse Aire versus huAIRE) and/
or promoter (CD11c versus MHC-II promoter) for transgenic 
expression might have accounted for the mechanistic differ-
ence between the two studies. Because the mode of action of 
huAIRE/Aire in peripheral APCs is a critical issue when using 
huAIRE/Aire as a tolerance modifier for self-antigen-specific 
immune responses, precise elucidation of the mechanisms 
awaits further studies.
It is interesting to note that expression of IGRP (16) and 
BDC antigen (p31) (17), both under control of the Aire pro-
moter, induced resistance to T1D in NOD when they were 
subjected to MHC-I-restricted NY8.3 TCR-Tg and MHC-II-
restricted BDC2.5 TCR-Tg, respectively. In contrast to these 
studies, our huAIRE-Tg was not designed to express any par-
ticular β-islet antigens. Instead, huAIRE itself was expressed 
in thymic and peripheral APCs. Furthermore, the resistance 
to T1D in our huAIRE-Tg was observed in a polyclonal setting 
without any crossing with TCR-Tg specific for β-islet antigens. 
In the reports discussed above (16, 17), the authors demon-
strated that IGRP and p31 expressed by BM-derived eTACs, 
which were distinct from conventional DCs, were respon-
sible for the deletional tolerance and dominant tolerance for 
diabetogenic T cells in the periphery, respectively (16, 17). 
Clearly, the resistance to T1D in huAIRE-Tg is not caused by 
the manipulation of eTACs because the originally reported 
eTACs belong to a non-DC subset: CD45lowEpCAMhighCD11c−
CD80lowCD86low (16, 17). Together, these results suggest that 
there are several different approaches for amelioration of T1D 
using huAIRE/Aire as a transgene itself and/or as a promoter 
to express β-islet-related antigens.
It has been clearly demonstrated that insulin plays a pri-
mary role in diabetogenesis in NOD: deletion of immuno-
logically relevant insulin molecules completely abrogates 
the development of T1D (7). Conversely, overexpression 
of preproinsulin 2 in NOD using the MHC-II promoter, as 
employed in the present study, substantially reduces the 
onset and severity of T1D (47). In this case, tolerance was 
induced not only by the BM-derived APCs but also by 
radioresistant thymic epithelial cells (TECs) in these animals 
(47). The authors further demonstrated that overexpression 
of preproinsulin 2 from TECs did not induce the production 
of Tregs specific for preproinsulin 2 (i.e. dominant tolerance). 
Instead, they suggested that overexpression of preproinsulin 
2 ensured recessive tolerance (i.e. clonal deletion) against 
preproinsulin 2 (47). Clearly, a difference in the transgenes 
(i.e. preproinsulin 2 versus huAIRE) rendered NOD resistant 
to T1D through different mechanisms, despite the fact that the 
same MHC-II promoter was used.
Given that huAIRE expression in mTECs resulted in reduced 
expression of Ins2 (19), the fact that mTECs from huAIRE-Tg 
had no major impact on the production of diabetogenic T 
cells revealed by BM chimeras (Fig. 1D) was somewhat unex-
pected. However, there is a precedent for Aire-deficient NOD 
in which reduced expression of Ins2 by mTECs conferred 
complete resistance to T1D (26, 48). One possible explan-
ation for the discrepancy between the reduced expression of 
Ins2 from mTECs and the resistance to T1D in Aire-deficient 
NOD might be the production of anti-IFN-α autoantibody that 
could be protective against the diabetogenic process, as re-
ported for patients with AIRE deficiency (49). However, pro-
duction of anti-IFN-α autoantibody has not been observed 
in Aire-deficient mice, at least on C57BL/6 (50) and BALB/c 
(51) backgrounds. Furthermore, a link between resistance to 
T1D and production of anti-IFN-α autoantibody in APECED 
patients has been recently challenged (52). Thus, further 
studies are required to clarify the exact role of endogenous 
Aire in T1D pathogenesis.
Finally, mTECs expressing huAIRE were differentially 
involved in the production of autoreactive T cells with 
distinct tissue specificity. Muscle-specific T cells were gen-
erated only when mTECs expressed a high level of huAIRE, 
whereas diabetogenic T cells were generated irrespective 
of huAIRE expression in mTECs. Because huAIRE expres-
sion in BM-derived APCs also showed a contrasting out-
come in terms of the tissue-specific immune response [i.e. 
amelioration of T1D (demonstrated in the present study) 
and a co-operative role in the induction of muscle-specific 
autoimmunity (19)], it might be possible to control the tissue-
specific immune responses positively or negatively by 
manipulating the activity of huAIRE/Aire in either the thymic 
or peripheral tolerance mechanism selectively, or both 
simultaneously.
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